Co-expression of EGF receptor, TGFα and S6 kinase is significantly associated with colorectal carcinomas with distant metastases at diagnosis

Virchows Archiv

Volumn 450, Issue 3, 2007, Pages 321-328

  Tampellini, Marco ^a   Longo, Marina ^a   Cappia, Susanna ^a   Bacillo, Elisa ^a   Alabiso, Irene ^a   Volante, Marco ^a   Dogliotti, Luigi ^a   Papotti, Mauro ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Colorectal carcinoma; EGFR; Immunohistochemistry; Metastases; S6K; TGF

Indexed keywords

CANCER GROWTH FACTOR; CANCER GROWTH FACTOR ALPHA; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; PARAFFIN; PROTEIN KINASE B; S6 KINASE; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER STAGING; COLORECTAL CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS;

ADENOCARCINOMA; AGED; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NEOPLASM METASTASIS; NEOPLASM STAGING; PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETROSPECTIVE STUDIES; RIBOSOMAL PROTEIN S6 KINASES; STAT3 TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR MARKERS, BIOLOGICAL;

EID: 33847742204     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-007-0370-2     Document Type: Article

References (22)

1. Atkins D, Reiffen KA, Tegtmeier CL, Winther H, Bonato MS, Storkel S (2004) Immunohistochemical detection of EGFR in paraffin-embedded tumour tissue: variation in staining intensity due to choice of fixative and storage time of tissue sections. J Histochem Cytochem 52:893-901
2. Awwad RA, Sergina N, Yang H, Ziober B, Willson JK, Zborowska E, Humphrey LE, Fan R, Ko TC, Brattain MG, Howell GM (2003) The role of transforming growth factor alpha in determining growth factor independence. Cancer Res 63:4731-4738
3. Black RJ, Bray F, Ferlay J, Parkin DM(1997) Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur J Cancer 33:1075-1107
4. Chung KY, Shia J, Kemeny NE, Shah M, Schwartz GK, Tse A, Hamilton A, Pan D, Schrag D, Schwartz L, Klimstra DS, Fridman D, Kelsen DP, Saltz LB (2005) Cetuximab shows activity in colorectal cancer patients with tumours that do not express the epidermal growth factor receptor by immunohistochemistry. J Clin Oncol 23:1803-1810
5. De Jong KP, Stellema R, Karrenbeld A, Koudstaal J, Gouw AS, Sluiter WJ, Peeters PM, Slooff MJ, De Vries EG (1998) Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumours. Hepatology 28:971-979
6. Goldstein NS, Armin M (2001) Epidermal growth factor receptor immunohistochemical reactivity in patients with American Joint Committee on Cancer stage IV colon adenocarcinoma: implications for a standardized scoring system. Cancer 92:1331-1346
7. Hanawa M, Suzuki S, Dobashi Y, Yamane T, Kono K, Enomoto N, Ooi A (2006) EGFR protein overexpression and gene amplification in squamous cell carcinomas of the esophagus. Int J Cancer 118:1173-1180
8. Harada H, Andersen JS, Mann M, Terada N, Korsmeyer SJ (2001) p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD. Proc Natl Acad Sci USA 98:9666-9670
9. Hemming AW, Davis NL, Kluftinger A, Robinson B, Quenville NF, Liseman B, LeRiche J (1992) Prognostic markers of colorectal cancer: an evaluation of DNA content, epidermal growth factor receptor, and KI 67. J Surg Oncol 51:147-152
10. Moroni M, Veronese S, Benvenuti S, Marrapese G, Sartore-Bianchi A, Di Nicolantonio F, Gambacorta M, Siena S, Bardelli A (2005) Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study. Lancet Oncol 6:279-286
11. O'Connell JB, Maggard MA, Ko CY (2004) Colon cancer survival rates with the new American Joint Committee on Cancer sixth edn. staging. J Natl Cancer Inst 96:1420-1425
12. Parkin DM, Pisani P, Ferlay J (1999) Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80:827-841
13. Radinsky R, Risin S, Fan D, Dong Z, Bielenberg D, Bucana CD, Fidler IJ (1995) Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells. Clin Cancer Res 1:19-31
14. Resnick MB, Routhier J, Konkin T, Sabo E, Pricolo VE (2004) Epidermal growth factor receptor, c-met, beta-catenin, and p53 expression as prognostic indicators in stage II colon cancer: a tissue microarray study. Clin Cancer Res 10:3069-3075
15. Salomon DS, Brandt R, Ciardiello F, Normanno N (1995) Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 19:183-232
16. Sawhney RS, Sharma B, Humphrey LE, Brattain MG (2003) Integrin ?2 and extracellular signal-regulated kinase are functionally linked in highly malignant autocrine transforming growth factor-?-driven colon cancer cells. J Biol Chem 278:19861-19869
17. Sawhney RS, Cookson MM, Sharma B, Hauser J, Brattain MG (2004) Autocrine transforming growth factor ? regulates cell adhesion by multiple signalling via specific phosphorylation sites of p70S6 kinase in colon cancer cells. J Biol Chem 279:47379-47390
18. Scartozzi M, Bearzi I, Berardi R, Mandolesi A, Pierantoni S, Casinu S (2006) Epidermal growth factor receptor (EGFR) downstream signaling pathway in primary colorectal tumours and related metastatic sites: optimizing EGFR target treatment options. Proceedings of the American Society of Clinical Oncology Gastrointestinal cancers symposium, San Francisco, CA, Jan 26-28
19. Spaulding DC, Spaulding BO (2002) Epidermal growth factor receptor expression and measurement in solid tumours. Semin Oncol 29:45-54
20. Westra JL, Plukker JT, Buys CH, Hofstra RM (2004) Genetic alterations in locally advanced stage II/III colon cancer: a search for prognostic markers. Clin Colorectal Cancer 4:252-259
21. Xu C, McLeod H (2004) Pharmacogenomic profiling of the PI3K/PTEN-AKT-mTOR pathway in common human tumours. Int J Oncol 24:893-900
22. Ziober BL, Willson JK, Humphrey LE, Childress-Fields K, Brattain MG (1993) Autocrine transforming growth factor-α is associated with progression of transformed properties in human colon cancer cells. J Biol Chem 268:691-698